Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
FRED LUBLIN
Listed Specialty: Neurology
5 E 98TH ST, 1ST FLOOR, NEW YORK, NY, 10029-6501
DR. FRED LUBLIN,
Yearly Payment Breakdown:
2018 Payments At a Glance
43
payments
$82,158
payment total
7
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
Category | Payments | Payment Value |
---|---|---|
Consulting |
15 | $36,814 |
Promotional Speaking/Other |
1 | $23,312 |
Travel and Lodging |
12 | $20,277 |
Food and Beverage |
14 | $1,739 |
Grant |
1 | $16 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
Product Name | Product Type | Payments† |
---|---|---|
COPAXONE |
drug |
$42,953 |
OCREVUS |
drug |
$11,837 |
MAVENCLAD |
drug |
$9,455 |
DISEASE STATE |
drug |
$9,007 |
Payments with no listed product |
N/A |
$8,838 |
MS DISEASE STATE |
drug |
$68 |
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. |
Payment Details in 2018
When | How Much | Related To | What For | From | Third Party Payee |
---|---|---|---|---|---|
Mar 22, 2018 | $23,312 | COPAXONE | Promotional Speaking/Other | TEVA PHARMACEUTICALS USA, INC. | |
Mar 22, 2018 | $16,369 | COPAXONE | Travel and Lodging | TEVA PHARMACEUTICALS USA, INC. | |
Aug 14, 2018 | $8,200 | MAVENCLAD | Consulting | EMD SERONO, INC. | |
Nov 13, 2018 | $5,000 | No Listed Product | Consulting | TEVA PHARMACEUTICALS USA, INC. | |
Jan 29, 2018 | $4,500 | OCREVUS | Consulting | GENENTECH, INC. | |
Oct 10, 2018 | $3,918 | DISEASE STATE | Consulting | GENZYME CORPORATION | |
Jul 12, 2018 | $3,918 | DISEASE STATE | Consulting | GENZYME CORPORATION | |
Jul 31, 2018 | $2,750 | No Listed Product | Consulting | ACTELION CLINICAL RESEARCH, INC. | |
Jun 30, 2018 | $1,987 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
Jun 30, 2018 | $1,473 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
Mar 22, 2018 | $1,247 | COPAXONE | Travel and Lodging | TEVA PHARMACEUTICALS USA, INC. | |
Mar 31, 2018 | $1,052 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
Jul 31, 2018 | $1,000 | No Listed Product | Consulting | ACTELION CLINICAL RESEARCH, INC. | |
Mar 31, 2018 | $892 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
Jul 19, 2018 | $821 | COPAXONE | Food and Beverage | TEVA PHARMACEUTICALS USA, INC. | |
Mar 31, 2018 | $706 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
Jan 29, 2018 | $541 | OCREVUS | Travel and Lodging | GENENTECH, INC. | |
Jun 8, 2018 | $539 | MAVENCLAD | Travel and Lodging | EMD SERONO, INC. | |
Oct 10, 2018 | $490 | DISEASE STATE | Consulting | GENZYME CORPORATION | |
Jul 12, 2018 | $490 | DISEASE STATE | Consulting | GENZYME CORPORATION | |
Mar 31, 2018 | $439 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
Jul 19, 2018 | $433 | COPAXONE | Travel and Lodging | TEVA PHARMACEUTICALS USA, INC. | |
Jul 19, 2018 | $322 | COPAXONE | Travel and Lodging | TEVA PHARMACEUTICALS USA, INC. | Icahn School of Medicine at Mount Sinai |
Jun 8, 2018 | $308 | MAVENCLAD | Travel and Lodging | EMD SERONO, INC. | |
Mar 22, 2018 | $238 | COPAXONE | Food and Beverage | TEVA PHARMACEUTICALS USA, INC. | |
Jan 29, 2018 | $196 | OCREVUS | Travel and Lodging | GENENTECH, INC. | |
Mar 22, 2018 | $176 | COPAXONE | Travel and Lodging | TEVA PHARMACEUTICALS USA, INC. | |
Jul 3, 2018 | $150 | MAVENCLAD | Food and Beverage | EMD SERONO, INC. | |
Jul 12, 2018 | $125 | DISEASE STATE | Food and Beverage | GENZYME CORPORATION | |
Aug 14, 2018 | $81 | MAVENCLAD | Travel and Lodging | EMD SERONO, INC. | |
Jun 8, 2018 | $72 | MAVENCLAD | Food and Beverage | EMD SERONO, INC. | |
Oct 10, 2018 | $68 | MS DISEASE STATE | Food and Beverage | GENZYME CORPORATION | |
Jan 30, 2018 | $51 | OCREVUS | Food and Beverage | GENENTECH, INC. | |
Jun 8, 2018 | $49 | MAVENCLAD | Food and Beverage | EMD SERONO, INC. | |
Oct 10, 2018 | $46 | No Listed Product | Food and Beverage | ACTELION PHARMACEUTICALS, LTD | |
Jul 12, 2018 | $38 | DISEASE STATE | Travel and Lodging | GENZYME CORPORATION | |
Jun 8, 2018 | $29 | MAVENCLAD | Food and Beverage | EMD SERONO, INC. | |
Jun 8, 2018 | $29 | MAVENCLAD | Food and Beverage | EMD SERONO, INC. | |
Oct 10, 2018 | $28 | DISEASE STATE | Travel and Lodging | GENZYME CORPORATION | |
Oct 12, 2018 | $21 | No Listed Product | Food and Beverage | ACTELION PHARMACEUTICALS, LTD | |
Oct 12, 2018 | $21 | No Listed Product | Food and Beverage | ACTELION PHARMACEUTICALS, LTD | |
May 8, 2018 | $20 | COPAXONE | Food and Beverage | TEVA PHARMACEUTICALS USA, INC. | |
Mar 22, 2018 | $16 | COPAXONE | Grant | TEVA PHARMACEUTICALS USA, INC. |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.